Page results
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
-
Health and wellbeing information for people affected by cancer.
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
Advice on socialising and managing friendships for young people living with fatigue syndromes.
-
This page explains what an intra-oral scanner is and what it is used for.
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
File results
-
FOI/2023/0729 - In-patient beds and operating theatres
-
FOI/2023/0736 - Placements in locked rehabilitation for adults with mental health diagnosis
-
FOI/2023/0737 - Cancelled appointments at maternity unit from December 2022
-
FOI/2023/0738 - Patients treated with Biologic medicines in gastroenterology
-
FOI/2023/0741 - Anaesthesia Associates staff
-
FOI/2023/0742 - Cancer treatments
-
FOI/2023/0751 - Patient numbers and drug spend for Waldenstrom's Macroglobulinaemia
-
FOI/2023/0752 - Cancer patient deaths whilst on waiting list
-
FOI/2023/0753 - Drug-related admissions in A&E 2018-2023
-
FOI/2023/0756 - Physician Associates and Anaesthesia Associates staff